Northwestern Medicine, Vitestro to collaborate
March 19, 2025—Northwestern Medicine and Vitestro announced a multiyear collaboration to advance automation in phlebotomy.
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
March 19, 2025—Northwestern Medicine and Vitestro announced a multiyear collaboration to advance automation in phlebotomy.
March 14, 2025—Bio-Rad Laboratories has received the EU quality management systems certificate under IVDR regulation (EU) 2017/746, enabling the CE-IVDR marking of 40 Exact Diagnostics infectious disease molecular quality controls.
March 11, 2025—Beckman Coulter Diagnostics announced that its DxC 500i clinical analyzer received FDA 510(k) clearance.
March 10, 2025—ARUP Laboratories announced the expansion of its AI-augmented screening tool for the detection of human gastrointestinal parasites to include wet-mount slides.
March 7, 2025—Qiagen announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use.
March 6, 2025—Vitestro unveiled its CE-marked Aletta Autonomous Robotic Phlebotomy Device.
March 4, 2025—Sysmex America announced the expansion of its 3-part differential automated hematology analyzer line with the XQ-320 for CBC testing.
March 3, 2025—The Diagnostic Medicine Consortium has officially launched, bringing together the Association for Pathology Informatics and Project Santa Fe Foundation and with the aim of adding other like-minded collaborating medical diagnostic societies.
Feb. 26, 2025—Q-linea announced that it has signed a second commercial contract for its ASTar instrumentation in the United States.
Feb. 25, 2025—Labcorp announced that its Labcorp Plasma Complete is now available for clinical use.